A Unifying Hypothesis Linking the Adverse Effects of Glitazones to Induced Testosterone Deficiency
2008
Glitazones and Testosterone Deficiency in Diabetes
publication
Evidence: moderate
Author Information
Author(s): Carruthers M, Trinick TR, Jankowska E, Traish AM
Hypothesis
Are the adverse effects of glitazones linked to induced testosterone deficiency?
Conclusion
Glitazones may cause testosterone deficiency, leading to various adverse effects in patients with Type 2 Diabetes Mellitus.
Supporting Evidence
- Low testosterone levels in men are linked to increased risk of Type 2 Diabetes Mellitus.
- Androgen deprivation therapy can lead to diabetes and cardiovascular events.
- Testosterone treatment in diabetic men improves insulin sensitivity and reduces fat.
- Glitazones have been shown to reduce testosterone and dihydrotestosterone levels.
Takeaway
Some diabetes medications might lower testosterone levels, which can cause health problems. This study looks at how that happens.
Methodology
The study reviews existing literature and suggests clinical studies to measure hormone levels in diabetic patients before and after glitazone treatment.
Limitations
The study relies on existing literature and does not present new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website